HEPA

Hepion Pharmaceuticals, Inc.

HEPA·426897302·UQ·Common Stock·Healthcare - Biotechnology

HEPA (Hepion Pharmaceuticals, Inc.) is held by 3 institutional investors as of Q2 2025. Largest holders: XTX Topco Ltd ($1,389), BARCLAYS PLC ($0), OSAIC HOLDINGS, INC. ($0). Net institutional sentiment: Bearish.

3
Holders
$1,389
Total Value
21% (14)
Consensus
3 buying - 11 selling
13F: Insider & Congress: Updated regularly
HEPA

Smart Money Verdict

View all
Loading verdict
Held by 3 funds

Who's Trading

Source dates: Price Sep 14, 2026 · Insiders Apr 27, 2026 · Activists none · Congress none

InsiderLSLoPriore Vincent SBuy $200KApr 21, 2026
InsiderASAppajosyula SireeshBuy $50KApr 21, 2026
InsiderSSStetz Gary S.Buy $50KApr 21, 2026
Checking access…

Top Holders

Checking access…
Action
New
17,361$1,3890.0%-10.71%
15
Exited
0(-100.0%)$10.0%-100.00%
0
New
1$00.0%-10.71%
17
Exited
0(-100.0%)$7,0000.0%-85.42%
0
Exited
0(-100.0%)$10.0%-99.99%
0
Exited
0(-100.0%)$00.0%-99.67%
0
Exited
0(-100.0%)$130.0%-99.86%
0
Exited
0(-100.0%)$6,6980.0%-85.42%
0
Exited
0(-100.0%)$7130.0%-99.67%
0
Exited
0(-100.0%)$670.0%-99.99%
0
Exited
0(-100.0%)$430.0%-85.42%
0
Exited
0(-100.0%)$20.0%-100.00%
0
Increased
3(+50.0%)$00.0%-99.99%
11
Exited
0(-100.0%)$00.0%-99.67%
0
HEPAHEPAHepion Pharmaceuticals, Inc.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used